Manas AI: Valuation, Funding & Investors
Manas AI is a full-stack, AI-native drug discovery and development company co-founded by Dr. Siddhartha Mukherjee, Reid Hoffman, and Ujjwal Singh. The company leverages neuro-symbolic, science-based foundational models to address inefficiencies in traditional drug development, aiming to create faster, cheaper, and more precise medicines. Headquartered in New York City, Manas AI combines world-class biomedical expertise with next-generation AI capabilities to pioneer a new era of targeted therapies.
Leadership & Board
- Current Number of Employees
- 32
- Current LinkedIn Followers
- 9,035
Latest Estimated Valuation
- Total Amount Raised
- $26M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $26M
- Latest Funding Round
- Seed Round
Employee Trend
Manas AI had 32 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Manas AI had 9,035 followers as of November 16, 2026. The number of followers increased by 39 (0.43%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Sep 23, 2025 | Seed Round | $26.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| General Catalyst | Seed Round |
| The General Partnership | Seed Round |
| Blitzscaling Ventures | Seed Round |
| Reid Hoffman | Seed Round |
| Wisdom Ventures | Seed Round |
| Westbound Equity Partners | Seed Round |
| Mosaic Ventures | Seed Round |
Similar Companies
A snapshot of private companies similar to Manas AI, helping you discover and navigate related company profiles.






